Lan, Joung-Liang <br/><br/>
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.  [electronic resource] 

 -  Annals of the rheumatic diseases  Oct 2011 
 - 1719-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2010.148783  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antirheumatic Agents--adverse effects<br/>Antiviral Agents--therapeutic use<br/>Arthritis, Rheumatoid--complications<br/>Etanercept<br/>Female<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B virus--isolation & purification<br/>Hepatitis B, Chronic--complications<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Immunosuppressive Agents--adverse effects<br/>Lamivudine--therapeutic use<br/>Male<br/>Middle Aged<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Retrospective Studies<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Viral Load<br/>Virus Activation--drug effects